Ocera Announces Successful Phase 1 Clinical Study of Orally-Administered OCR-002 in Patients with Cirrhosis Life Science Investing
Q BioMed Inc. to Present at Biotech Showcase 2017 in San Francisco Jan 9 – 11th Life Science Investing
OncoMed Initiates Enrollment of Phase 1b Clinical Trial for Metastatic Colorectal Cancer Patients Life Science Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â